In this session moderated by Dr Reshma Mahtani, the panel will consider the use of adjuvant treatments in the setting of patients with early stage, hormone receptor positive HER2 negative breast cancer.
You'll never get an answer from these people. She already had the adjuvant therapy now her metabolic system needs to be on target, and all external environmental elements that are in personal healthcare, and foods to utensils must be avoided .
